LifeStance director granted 17,746 RSUs
LifeStance Health Group director Teresa DeLuca received an equity grant.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
LifeStance Health Group director Teresa DeLuca received an equity grant. She acquired 17,746 shares of common stock in the form of restricted stock units (RSUs), which are rights to receive one share of common stock per unit at no cash cost. After this award, she directly holds 125,034 shares of the company’s common stock, indicating a larger equity stake aligned with shareholder interests through stock-based compensation rather than open-market purchases or sales.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 17,746 | $0.00 | $0.00 |
Footnotes (1)
- F1. Includes 17,746 restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock.
Key Figures
Key Terms
restricted stock units financial
RSUs financial
Grant, award, or other acquisition financial
Form 4 regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did LifeStance Health (LFST) director Teresa DeLuca report on this Form 4?
Is the LifeStance Health (LFST) Form 4 a stock purchase or a grant?
What are the restricted stock units (RSUs) reported in the LifeStance (LFST) Form 4?
Does this LifeStance Health (LFST) insider filing show any stock sales?
AI-generated analysis. How Rhea-AI works. Not financial advice.